ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2013

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin.

Eleonora Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.